Brain-Focused Startup Oyster Gets $60M to Beat the Size Problem for Small Molecule Degraders
Oyster Therapeutics’ lead program penetrates the brain to degrade pathological tau associated with Alzheimer’s disease….
Oyster Therapeutics’ lead program penetrates the brain to degrade pathological tau associated with Alzheimer’s disease. Eli Lilly, maker of the amyloid-targeting Alzheimer’s drug Kisunla, participated in the startup’s new financing. The post Brain-Focused Startup Oyster Gets $60M to Beat the Size Problem for Small Molecule Degraders appeared first on MedCity News.
We are investing billions in making cancer treatment more precise while too many patients still can’t reliably reach the healthcare system delivering it. That should trouble all of us. The post The Zip Code Trap: Why Geography Might Be a Better Predictor of Cancer Survival Than DNA appeared first on MedCity News.
Company says its Synapsis AI reads a patient’s longitudinal record and answers clinical questions with evidence from the chart.
The U.S. has officially lost its status as a country where measles is eliminated, a public health triumph secured a quarter century ago. Researchers with direct knowledge of the deliberations on the country’s status told KFF Health News that the Pan American Health Organization reached the conclusion this week: Measles has reestablished regular transmission in…
KFF Health News senior correspondent Julie Appleby joined WBUR’s Here & Now on Nov. 11 to discuss how a fraud crackdown is making Affordable Care Act open enrollment more difficult. Appleby also discussed the expected rise in premiums, deductibles, and copays for Medicare and employer-based healthcare plans on WVXU’s Cincinnati Edition on Nov. 9. Click…
The Series B round was led by Drive Capital, with participation from Sanofi Ventures, HealthX Ventures, Alumni Ventures, Andreessen Horowitz (a16z), F-Prime, Maverick Ventures and JAZZ Venture Partners. The post Zus Health Raises $33M to Make Healthcare More Connected appeared first on MedCity News.
The team led by new CEO Dave Caspers recently said they would divest their stake in a Topeka hospital network.
[Sponsored] ARPA-H portfolio companies in the Innovation Showcase included biosensor and wearable startups to monitor vital signs and to obtain patient data previously only available through blood tests. The post Biosensors and Wearables Among MedTech Showcased at INVEST Digital Health appeared first on MedCity News.
To shed greater light on U.S. global health efforts under the AFGHS, this analysis examines the Advancing Global Health APS (AGH/APS) award opportunities announced to date by looking at how funding may be directed across countries and selected areas of global health programming, painting a fuller picture of how continued U.S. global health investment may…
Windward Bio’s next-generation antibody drugs for immunology caught the interest of Sanofi, which bought shares in a private placement alongside the biotech’s IPO. Windward’s lead drug candidate addresses the same target as a blockbuster asthma drug from partners Amgen and AstraZeneca. The post Windward Bio’s Stock Market Debut Reels In $225M for Better Biologic Drugs…